Navigation Links
7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
Date:3/5/2012

(Baton Rouge, March 5, 2012) The International Rett Syndrome Foundation (IRSF) has named local resident Kathryn Schanen Kissam as Chair of the 7th World Congress for Rett Syndrome. The World Congress will consist of four interconnected meetings targeting researchers, clinicians, medical professionals and families impacted by Rett syndrome. These meetings include a Family Education Conference and a Science Symposium co-chaired by renowned Howard Hughes Medical Institute researchers Huda Zoghbi, M.D., Baylor College of Medicine and Director of the Jan and Dan Duncan Neurological Institute and Gail Mandel, Ph.D. Vollum Institute, Oregon Health and Science University.

"The objective of the World Congress is to accelerate treatments and a cure of Rett syndrome and related disorders by stimulating and accelerating novel global research and establishing current standards of care and I'm truly honored to be named Chair." said Kissam. "Families affected by Rett syndrome across the globe need access to the tools and knowledge necessary to improve health and quality of life," she said. Kissam has served as Chairman of IRSF since 2003.

Louisiana's First Lady Supriya Jindal joined Kissam in welcoming the World Congress to Louisiana saying, "We are delighted that New Orleans has been selected as the first United States host city for the 7th World Congress on Rett syndrome. I'm honored to welcome many of the world's most prominent Rett syndrome professionals to our state to uncover ways to benefit families affected by Rett and many other related neurological conditions."

IRSF is holding the World Congress in the U.S. for the first time. Previous sites have included Paris, Ottawa, Vienna and Tokyo.


'/>"/>

Contact: Paige Nues
pnues@rettsyndrome.org
510-499-3858
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. UMD and Chinese partner to track and predict world climate change
2. Researchers develop worlds first biodegradable joint implant
3. World nourishment at risk of being diminished: Wild cereals threatened by global warming
4. Press registration open for World Series of Science
5. Window into worlds future oceans unveiled by NF-UBC Nereus team
6. Revealed in accurate detail, the underground world of plants
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Worlds greenest supercomputer heads to Melbourne to boost health research
9. World class to second class? Confronting the risks to US science and innovation
10. Are nuisance jellyfish really taking over the worlds oceans?
11. Satellite study reveals critical habitat and corridors for worlds rarest gorilla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:8/21/2017)... (PRWEB) , ... August 20, 2017 , ... ... Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is published ... Biomedical Optics publishes papers on the use of modern optical technology for improved ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... webinar, in which attendees will learn about the assembly and topological architecture of ... an overview of the development and validation of new high-quality recombinant monoclonal antibodies, ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... and personalized medicine, today announced the launch of a new breast cancer monitoring ... study’s goal is to evaluate the potential for early detection of recurrent breast ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar ... has secured $2M in funding from an impressive group of investors, including Rev1 ... Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering ...
Breaking Biology Technology: